Research and Markets: GCC Select Cardiovascular Drugs Market 2012-16 - Analysis of the $7.6 Billion Industry

Research and Markets (http://www.researchandmarkets.com/research/kx9zr7/market_for_select) has announced the addition of the "GCC Select Cardiovascular Drugs Market 2012-16 - Analysis of the $7.6 Billion Industry" report to their offering.

This report focuses on the market for select cardiovascular drugs in the GCC region. Various market drivers in terms of changing lifestyle and rising disease incidence among the population has led to higher consumption of cardiovascular drugs in the region. Sensing the latent market opportunity, global pharma majors such as Novartis, Abbott, AstraZeneca have set up operations in the GCC region through local joint venture and distribution.

The $7.6 bn Pharmaceutical industry in the GCC region is poised for major growth in the coming years. Increase in the international crude oil prices and exports of crude and petro products have transformed the GCC economy. The local governments are increasingly focusing on improving the health and living standards of the population. Constraints in local manufacturing capacity and thriving counterfeit drugs market pose a major challenge but improved regulatory mechanism, increase in private sector participation coupled with rising private and public sector outlay and spend on healthcare presents a promising future for the industry.

In addition to market forecast up to 2016, the report also provides interesting insights into key molecules used, top brands, drug prices, procurement process among government and retail institutions. The report will serve as a effective guide for the drug companies, distributors, hospitals and other stakeholders who wish to enter the GCC healthcare market. The report also has profiles of companies and distributors in the GCC region.

Key Topics Covered:

1. Methodology

2. Report Coverage

3. Glossary of terms

4. Executive summary

5. Healthcare sector in GCC

6. Pharmaceutical market in GCC

7. Cardiovascular market for select drugs in GCC

8. Profiles of key domestic pharmaceutical manufacturers

9. Annexure - Drugs price details by country - 2012

Companies Mentioned:

• AstraZeneca
• Global Pharma
• Jamjoom Pharma
• Julphar - Gulf Pharmaceutical Industries
• Kuwait Saudi Pharmaceutical Industries
• Merck & Co., Inc
• National Pharmaceutical Industries Co
• Neo Pharma
• Novartis International AG
• Oman Pharmaceutical Products Co. L.L.C
• Pfizer, Inc
• Sanofi S.A.
• Saudi Pharmaceutical Industries & Medical Appliances Corporation
• Tabuk Pharmaceuticals Manufacturing Company

For more information visit http://www.researchandmarkets.com/research/kx9zr7/market_for_select